Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|March 29, 2003
Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infectionFatih Besisik, Cetin Karaca, Filiz Akyüz, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2021
Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological StudyOguz Kagan Bakkaloglu, Ozgen Yildirim, Bilger Cavus, et al.
Gastrointestinal Endoscopy|November 3, 2009
Feasibility of endoscopic transesophageal thoracic sympathectomy (with video)Brian G Turner, Denise W Gee, Sevdenur Cizginer, et al.
Phytotherapy Research : PTR|May 16, 2012
Effects of Crataegus microphylla on vascular dysfunction in streptozotocin-induced diabetic ratsGökçe Topal, Ebru Koç, Cetin Karaca, et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|December 6, 2016
Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinomaRaim Iliaz, Umit Akyuz, Didem Tekin, et al.
Postgraduate Medicine|April 8, 2016
Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort studyOzlem Mutluay Soyer, Bulent Baran, Aslı Ciftcibasi Ormeci, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|September 28, 2011
Effects of lycopene on oxidative stress and remnant liver histology after partial hepatectomy in ratsErman Aytac, Fadıl Ayan, Seha Saygili, et al.
World Journal of Gastrointestinal Endoscopy|April 15, 2016
What is the impact of capsule endoscopy in the long term period?Asli Ormeci, Filiz Akyuz, Bulent Baran, et al.
Medicine|January 11, 2017
Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: A retrospective cohort studyOzlem Mutluay Soyer, Bulent Baran, Asli Ciftcibasi Ormeci, et al.
Hepato-Gastroenterology|December 3, 2009
Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?Veysel Tahan, Resat Ozaras, Cetin Karaca, et al.
Pageof 7